| Name | Title | Contact Details |
|---|
PureLine Genetics is a Preston, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kindbody is reinventing healthcare for the modern family, starting with fertility, family-building and wellness benefits. Through a national network of locations, Kindbody is bringing together clinical excellence, best-in-class technology, and accessible pricing — connecting the full patient experience in one, intuitive platform.
At UnitedHealthcare we`re dedicated to helping people live healthier lives and helping to make the health system work better for everyone by simplifying the health care experience, meeting consumer health needs and sustaining trusted relationships with care providers. These are extraordinary times in health care. The opportunities to help people live healthier have never been greater. Advanced data and technologies, breakthrough treatments and consumer choice are redefining what can be achieved. At UnitedHealthcare, part of the UnitedHealth Group family of businesses, we are working to create a system that is connected, aligned and more affordable for all involved; one that delivers high quality care, responsive to the needs of each person and the communities in which they live. With connections to more than 1.3 million physicians and care professionals and 6,200+ hospitals and care facilities across the globe, we can collaborate in new ways to improve patient care while providing customizable and comprehensive solutions in any market place, anywhere. Our Values Integrity: Honor commitments. Never compromise ethics. Compassion: Walk in the shoes of people we serve and those with whom we work. Relationships: Build trust through collaboration. Innovation: Invent the future, learn from the past. Performance: Demonstrate excellence in everything we do.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Creative Health Care Management is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.